Silveira-Moriyama L, Mathias C, Mason L, Best C, Quinn N P, Lees A J
Reta Lila Weston Institute of Neurological Studies and Queen Square Brain Bank for Neurological Diseases, UCL Institute of Neurology, London, UK.
Neurology. 2009 May 12;72(19):1677-81. doi: 10.1212/WNL.0b013e3181a55fd2.
Parkinson disease (PD), multiple system atrophy (MSA), and pure autonomic failure (PAF) all present with varying degrees of dysautonomia and are pathologically characterized by accumulation of alpha-synuclein. Hyposmia and olfactory pathway pathology are found in PD and MSA. We tested odor identification in 16 patients with PAF and compared the results with those found in patients with PD, patients with MSA, and control subjects.
The University of Pennsylvania Smell Identification Test (UPSIT) was used to evaluate the sense of smell in 16 patients with PAF, 14 patients with MSA, 191 patients with PD, and 145 control subjects. Multiple linear regression analyses were used to evaluate the effect of the diseases on the mean UPSIT score when adjusted for age, sex, and smoking habit.
The mean UPSIT score was higher in the controls than in patients with PAF (p < 0.001) or MSA (p < 0.001); it was lower in patients with PD than in patients with PAF (p = 0.005) or patients with MSA (p = 0.006); and no difference was found between patients with MSA and patients with PAF (p = 0.9) when adjusted for age, gender, and smoking habits.
Hyposmia may be a feature of pure autonomic failure (PAF), but to a lesser degree than that found in Parkinson disease. Further research into the olfactory pathways in patients with PAF is warranted.
帕金森病(PD)、多系统萎缩(MSA)和单纯自主神经功能衰竭(PAF)均表现出不同程度的自主神经功能障碍,其病理特征为α-突触核蛋白的积累。嗅觉减退和嗅觉通路病理改变在PD和MSA中均有发现。我们对16例PAF患者进行了气味识别测试,并将结果与PD患者、MSA患者及对照受试者的结果进行比较。
采用宾夕法尼亚大学嗅觉识别测试(UPSIT)对16例PAF患者、14例MSA患者、191例PD患者和145例对照受试者的嗅觉进行评估。采用多元线性回归分析评估疾病对调整年龄、性别和吸烟习惯后的UPSIT平均得分的影响。
对照受试者的UPSIT平均得分高于PAF患者(p < 0.001)或MSA患者(p < 0.001);PD患者的得分低于PAF患者(p = 0.005)或MSA患者(p = 0.006);在调整年龄、性别和吸烟习惯后,MSA患者与PAF患者之间未发现差异(p = 0.9)。
嗅觉减退可能是单纯自主神经功能衰竭(PAF)的一个特征,但程度低于帕金森病。有必要对PAF患者的嗅觉通路进行进一步研究。